Economic Evaluation of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease

医学 部分流量储备 经皮冠状动脉介入治疗 生活质量(医疗保健) 置信区间 冠状动脉疾病 质量调整寿命年 成本效益 经皮 心脏病学 内科学 急诊医学 冠状动脉造影 心肌梗塞 风险分析(工程) 护理部
作者
William F. Fearon,Bernhard Bornschein,Pim A.L. Tonino,Raffaella Matteucci Gothe,Bernard De Bruyne,Nico H.J. Pijls,Uwe Siebert
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:122 (24): 2545-2550 被引量:358
标识
DOI:10.1161/circulationaha.109.925396
摘要

The Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) study demonstrated significantly improved health outcomes at 1 year in patients randomized to multivessel percutaneous coronary intervention guided by fractional flow reserve (FFR) compared with percutaneous coronary intervention guided by angiography alone. The economic impact of routine measurement of FFR in this setting is not known.In this study, 1005 patients were randomly assigned to FFR-guided or angiography-guided percutaneous coronary intervention and followed up for 1 year. A prospective cost-utility analysis comparing costs and quality-adjusted life-years was performed with a time horizon of 1 year. Quality-adjusted life-years were calculated with the use of utilities determined by the EuroQuol 5 dimension health survey with US weights. Direct medical costs included those of the index procedure and hospitalization and costs for major adverse cardiac events during follow-up. Confidence intervals for both quality-adjusted life-years and costs were estimated by the bootstrap percentile method. Major adverse cardiac events at 1 year occurred in 13.2% of those in the FFR-guided arm and 18.3% of those in the angiography-guided arm (P=0.02). Quality-adjusted life-years were slightly greater in the FFR-guided arm (0.853 versus 0.838; P=0.2). Mean overall costs at 1 year were significantly less in the FFR-guided arm ($14 315 versus $16 700; P<0.001). Bootstrap simulation indicated that the FFR-guided strategy was cost-saving in 90.74% and cost-effective at a threshold of US $50 000 per quality-adjusted life-years in 99.96%. Sensitivity analyses demonstrated robust results.Economic evaluation of the FAME study reveals that FFR-guided percutaneous coronary intervention in patients with multivessel coronary disease is one of those rare situations in which a new technology not only improves outcomes but also saves resources. Clinical Trial Registration- URL: http://ClinicalTrials.gov. Unique identifier: NCT00267774.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
chen应助11111采纳,获得10
刚刚
刚刚
刚刚
CXS完成签到,获得积分10
3秒前
3秒前
wang35发布了新的文献求助60
4秒前
优雅的千凝完成签到,获得积分10
4秒前
Accept2024完成签到,获得积分10
6秒前
背后海亦应助璇璇采纳,获得20
6秒前
方QL发布了新的文献求助10
6秒前
wang完成签到,获得积分0
8秒前
小陆完成签到,获得积分10
9秒前
听雪冬眠完成签到,获得积分10
12秒前
擦撒擦擦发布了新的文献求助10
14秒前
踏实采波完成签到,获得积分10
16秒前
传奇3应助方QL采纳,获得10
18秒前
18秒前
orange完成签到,获得积分10
21秒前
23秒前
zzzzz完成签到,获得积分10
25秒前
Tarius发布了新的文献求助10
26秒前
27秒前
eslic完成签到,获得积分20
28秒前
Lucas应助Bkpp采纳,获得10
28秒前
29秒前
30秒前
深情的雁露完成签到 ,获得积分10
31秒前
32秒前
Faded完成签到 ,获得积分10
32秒前
田茂青完成签到,获得积分10
33秒前
南海神尼完成签到,获得积分10
33秒前
南淮发布了新的文献求助10
34秒前
34秒前
平淡的依白完成签到,获得积分20
34秒前
IvyLee发布了新的文献求助10
35秒前
37秒前
卢彦冬完成签到,获得积分10
37秒前
dddd完成签到,获得积分10
38秒前
温冰雪完成签到,获得积分10
41秒前
大秋哥哈拉少完成签到,获得积分10
42秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
Interpretation of Mass Spectra, Fourth Edition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3950988
求助须知:如何正确求助?哪些是违规求助? 3496397
关于积分的说明 11081817
捐赠科研通 3226886
什么是DOI,文献DOI怎么找? 1784005
邀请新用户注册赠送积分活动 868114
科研通“疑难数据库(出版商)”最低求助积分说明 800997